Search

for
Search:

Did you mean Sezary's syndrome?

GlossarySézary syndrome

rare, aggressive skin cancer involving malignant T-cells

Sézary syndrome is a rare and aggressive form of cutaneous T-cell lymphoma, a type of cancer that originates in the T-lymphocytes (a kind of white blood cell) and primarily affects the skin. It is characterized by the presence of cancerous T-cells in the blood, skin, and lymph nodes, leading to symptoms such as red, itchy, and scaly skin, enlarged lymph nodes, and sometimes hair loss.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 142 results

research Cutaneous T-Cell Lymphoma Outcomes During COVID-19

September 2021 in “Journal of the American Academy of Dermatology”

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

research The Spectrum of Hair Loss in Patients with Mycosis Fungoides and Sézary Syndrome

39 citations , October 2010 in “Journal of The American Academy of Dermatology”

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

research Proteomics and Transcriptomics Profiling Define Molecular Subtypes of Advanced Cutaneous T Cell Lymphoma and Prognostic Biomarkers

July 2025 in “Journal of Investigative Dermatology”

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

The Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study Identifies Clinical Prognostic Markers and Establishes the Foundation for Large-Scale Translational Research in Cutaneous Lymphoma

research The Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study Identifies Clinical Prognostic Markers and Establishes the Foundation for Large-Scale Translational Research in Cutaneous Lymphoma

April 2019 in “Journal of Investigative Dermatology”

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

research Alopecia Areata After Mogamulizumab Treatment

7 citations , November 2021 in “JAAD Case Reports”

Mogamulizumab can cause hair loss and skin rashes.

View more "sezarys syndrome" in research →

Community Join

0 / 0 results

— no results